Global Travelers Vaccines Market Growth 2025-2031

The global Travelers Vaccines market size is predicted to grow from US$ 3890 million in 2025 to US$ 6570 million in 2031; it is expected to grow at a CAGR of 9.1% from 2025 to 2031.

A vaccine is a biological preparation that improves immunity to a particular disease. A vaccine typically contains an agent that resembles a disease-causing microorganism, and is often made from weakened or killed forms of the microbe, its toxins or one of its surface proteins. The agent stimulates the body"s immune system to recognize the agent as foreign, destroy it, and "remember" it, so that the immune system can more easily recognize and destroy any of these microorganisms that it later encounters.

Travelers are at increased risk for several infections, including familiar infections such as measles that are widely distributed but more common in developing countries. Travelers Vaccines can markedly decrease the risk for many of these infections and are an important part of pretravel preparation.

In this report, the travelers vaccines mainly covers vaccine for hepatitis A, hepatitis B, rabies, typhoid fever, yellow fever, Japanese encephalitis, meningococcal meningitis, cholera, etc.

Merck, GlaxoSmithKline and Sanofi Pasteur are the main manufacturers in the vaccine market, with a market share of more than 60% and a high degree of market concentration. North America and Europe are the main production regions, with market share of more than 40% and 30%.

LP Information, Inc. (LPI) ' newest research report, the “Travelers Vaccines Industry Forecast” looks at past sales and reviews total world Travelers Vaccines sales in 2024, providing a comprehensive analysis by region and market sector of projected Travelers Vaccines sales for 2025 through 2031. With Travelers Vaccines sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Travelers Vaccines industry.

This Insight Report provides a comprehensive analysis of the global Travelers Vaccines landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Travelers Vaccines portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Travelers Vaccines market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Travelers Vaccines and breaks down the forecast by Type, by End Users, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Travelers Vaccines.

This report presents a comprehensive overview, market shares, and growth opportunities of Travelers Vaccines market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:
Meningococcal Vaccine
Japanese Encephalitis Vaccine
Yellow Fever Vaccine
Hepatitis Vaccine
Cholera Vaccine
Other

Segmentation by End Users:
Tourists
Students
Workers
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
GlaxoSmithKline
Sanofi Pasteur
Merck
Pfizer
CNBG
Sanofi Pasteur MSD
Serum Institute of India
Biokangtai

Key Questions Addressed in this Report

What is the 10-year outlook for the global Travelers Vaccines market?

What factors are driving Travelers Vaccines market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Travelers Vaccines market opportunities vary by end market size?

How does Travelers Vaccines break out by Type, by End Users?

Please note: The report will take approximately 2 business days to prepare and deliver.